Inventor
BLANKENSTEIN THOMAS
DE12 patents
⚠️ This page may combine multiple inventors who share the name “BLANKENSTEIN THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT
4 patentsUS11401316B2Aug 2, 2022
High avidity HPV T-cell receptors
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT0 citations53
US12421290B2Sep 23, 2025
CD22-specific T cell receptors and adoptive T cell therapy for treatment of B cell malignancies
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT0 citations51
US12479903B2Nov 25, 2025
CD5 specific T cell receptor cell or gene therapy
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT0 citations49
US10781243B2Sep 22, 2020
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT0 citations44
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN MDC BERLIN BUCH
3 patentsUS12338272B2Jun 24, 2025
High avidity antigen recognizing constructs
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN MDC BERLIN BUCH0 citations54
US11447536B2Sep 20, 2022
High avidity antigen recognizing constructs
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN MDC BERLIN BUCH0 citations54
US10683336B2Jun 16, 2020
Tumor specific T-cell receptors
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN MDC BERLIN BUCH0 citations30